Dronedarone (Multaq) for atrial fibrillation.
Dronedarone (Multaq - Sanofi-Aventis) has been approved by the FDA for oral treatment of atrial fibrillation and flutter. Amiodarone (Cordarone, and others) is the most effective drug for this indication, but has considerable toxicity.
D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000077764:Dronedarone; D004347:Drug Interactions; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000889:Anti-Arrhythmia Agents; D000077764:Dronedarone; D000638:Amiodarone